awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37153437-2201907C-1464-45A0-8D6C-0D31341AD5DB
Q37153437-2201907C-1464-45A0-8D6C-0D31341AD5DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37153437-2201907C-1464-45A0-8D6C-0D31341AD5DB
Adjuvant therapy in renal cell carcinoma-past, present, and future.
P2860
Q37153437-2201907C-1464-45A0-8D6C-0D31341AD5DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37153437-2201907C-1464-45A0-8D6C-0D31341AD5DB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
512edaeeadc3cd19434a48de06c18d005393f311
P2860
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling